A Public Health Approach to Hepatitis C in an Urban Setting
- PMID: 28426310
- PMCID: PMC5425859
- DOI: 10.2105/AJPH.2017.303718
A Public Health Approach to Hepatitis C in an Urban Setting
Abstract
The clinical consequences of HCV infection are increasing because the population with the highest prevalence of the infection, persons born between 1945 and 1965, is aging. As a result, health care expenditures are expected to increase. Now that a cure for HCV infection is the norm, a public health approach is necessary to identify, link to care, and treat infected persons and prevent new infections. We believe that the success of public health interventions, such as those for tuberculosis, can be translated to HCV infection. New York City has many HCV-infected residents and has developed a public health approach to controlling the HCV epidemic. It encompasses surveillance and monitoring, case finding, linkage to care, care coordination, increasing clinical provider capacity for screening and treatment, increasing public awareness, and primary prevention.
Figures
References
-
- Trooskin SB, Reynolds H, Kostman JR. Access to costly new hepatitis C drugs: medicine, money, and advocacy. Clin Infect Dis. 2015;61(12):1825–1830. - PubMed
-
- Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE. Restrictions for Medicaid reimbursement of Sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med. 2015;163(3):215–223. - PubMed
-
- Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26(3) suppl 1:15S–20S. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
